Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer

Background/Aim: Published data have shown that palbociclib-fulvestrant can significantly improve the progression-free survival (PFS) of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) metastatic breast cancer patients, but not of Japanese patients. We conduct...

全面介紹

Na minha lista:
書目詳細資料
發表在:In Vivo
Main Authors: SEKI, HIROHITO, SAKURAI, TAKASHI, MAEDA, YUKA, OKI, NAOHIKO, AOYAMA, MINA, YAMAGUCHI, RYOU, TOKUDA, TOSHIKI, KABURAGI, TAKUJI, OKUMURA, TAKEHIRO, KARAHASHI, TSUYOSHI, NAKAJIMA, KENICHIRO, HIGETA, KAORI, SHIMIZU, KEN
格式: Artigo
語言:Inglês
出版: International Institute of Anticancer Research 2019
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899113/
https://ncbi.nlm.nih.gov/pubmed/31662535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11701
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍